annb0t
Top 20
Wall Street analysts expect ResMed (RMD) to post quarterly earnings of $1.80 per share in its upcoming report, which indicates a year-over-year increase of 8.4%. Revenues are expected to be $1.16 billion, up 12.3% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.8% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a compan...
>>> Read more: Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street's Insights on Key Metrics
The consensus EPS estimate for the quarter has been revised 0.8% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a compan...
>>> Read more: Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street's Insights on Key Metrics
